ADAR1 Capital Management
Latest statistics and disclosures from ADAR1 Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ABVX, KROS, SPY, PTGX, ROIV, and represent 35.98% of ADAR1 Capital Management's stock portfolio.
- Added to shares of these 10 stocks: IMVT (+$28M), SPY (+$25M), ROIV (+$21M), QURE (+$20M), ETNB (+$18M), LXEO (+$9.2M), CRNX (+$8.1M), IVVD (+$8.1M), MTSR (+$8.0M), EQ (+$8.0M).
- Started 49 new stock positions in SUPN, BNTX, Bridgebio Oncology Therapeut, FDMT, SABS, DAY, Mei Pharma, ASMB, STI, MAZE.
- Reduced shares in these 10 stocks: Bridgebio Pharma (-$440M), Bridgebio Pharma (-$278M), ABVX (-$146M), PRTA (-$19M), CGON (-$11M), MLYS (-$8.5M), RAPT (-$7.1M), SAGE (-$6.6M), CNTA (-$5.9M), SVRA (-$5.8M).
- Sold out of its positions in ALDX, ALEC, AVXL, APGE, ARDX, ARGX, AUPH, BCAB, BPMC, BOLT.
- ADAR1 Capital Management was a net seller of stock by $-717M.
- ADAR1 Capital Management has $1.1B in assets under management (AUM), dropping by 63.26%.
- Central Index Key (CIK): 0001940272
Tip: Access up to 7 years of quarterly data
Positions held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for ADAR1 Capital Management
ADAR1 Capital Management holds 203 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Abivax Sa Sponsored Ads (ABVX) | 10.8 | $115M | -56% | 1.4M | 84.90 |
|
| Keros Therapeutics (KROS) | 8.0 | $85M | 5.4M | 15.82 |
|
|
| Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) | 6.3 | $67M | +58% | 100k | 666.18 |
|
| Protagonist Therapeutics (PTGX) | 6.2 | $66M | +4% | 989k | 66.43 |
|
| Roivant Sciences SHS (ROIV) | 4.8 | $51M | +72% | 3.3M | 15.13 |
|
| Ea Series Trust Alpha Arch 1-3 (BOXX) | 3.6 | $38M | 337k | 113.86 |
|
|
| Immunovant (IMVT) | 3.4 | $36M | +318% | 2.2M | 16.12 |
|
| 89bio (ETNB) | 2.9 | $31M | +141% | 2.1M | 14.70 |
|
| Zai Lab Adr (ZLAB) | 2.8 | $29M | +2% | 869k | 33.89 |
|
| Cytokinetics Com New (CYTK) | 2.7 | $29M | -10% | 519k | 54.96 |
|
| Septerna (SEPN) | 2.1 | $22M | +38% | 1.2M | 18.81 |
|
| Uniqure Nv SHS (QURE) | 1.8 | $20M | NEW | 333k | 58.37 |
|
| Prothena Corp SHS (PRTA) | 1.3 | $14M | -56% | 1.5M | 9.76 |
|
| Bridgebio Pharma (BBIO) | 1.3 | $14M | +5% | 273k | 51.94 |
|
| Arbutus Biopharma (ABUS) | 1.2 | $13M | +2% | 2.9M | 4.54 |
|
| Rapt Therapeutics Com New (RAPT) | 1.2 | $13M | -35% | 508k | 25.79 |
|
| Cytomx Therapeutics (CTMX) | 1.2 | $13M | +31% | 4.0M | 3.19 |
|
| Spdr Series Trust Bloomberg 1-3 Mo (BIL) | 1.2 | $12M | 136k | 91.75 |
|
|
| Amylyx Pharmaceuticals (AMLX) | 1.1 | $12M | -28% | 866k | 13.59 |
|
| Bioage Labs (BIOA) | 1.0 | $11M | -2% | 1.9M | 5.88 |
|
| Monopar Therapeutics Com New (MNPR) | 1.0 | $11M | +28% | 130k | 81.67 |
|
| Aa Mission Acquisition Corp Ord Shs Cl A (AAM) | 1.0 | $10M | +70% | 983k | 10.52 |
|
| Crinetics Pharmaceuticals In (CRNX) | 1.0 | $10M | +367% | 248k | 41.65 |
|
| Lexeo Therapeutics (LXEO) | 1.0 | $10M | +955% | 1.5M | 6.64 |
|
| Cg Oncology (CGON) | 0.9 | $10M | -52% | 249k | 40.28 |
|
| Taysha Gene Therapies Com Shs (TSHA) | 0.9 | $9.3M | -5% | 2.8M | 3.27 |
|
| Regeneron Pharmaceuticals (REGN) | 0.8 | $8.8M | +367% | 16k | 562.27 |
|
| Ionis Pharmaceuticals (IONS) | 0.8 | $8.8M | -9% | 134k | 65.42 |
|
| Janux Therapeutics (JANX) | 0.8 | $8.6M | +7% | 351k | 24.44 |
|
| Inhibikase Therapeutics Com New (IKT) | 0.8 | $8.5M | +2% | 5.2M | 1.62 |
|
| Adagio Therapeutics (IVVD) | 0.8 | $8.1M | NEW | 7.4M | 1.10 |
|
| Mestera (MTSR) | 0.7 | $8.0M | NEW | 153k | 52.33 |
|
| Equillium (EQ) | 0.7 | $8.0M | NEW | 5.6M | 1.43 |
|
| Perceptive Cap Solutions Cor Cl A Ord Shs (PCSC) | 0.7 | $7.9M | 750k | 10.56 |
|
|
| Vaxcyte (PCVX) | 0.7 | $7.7M | +117% | 213k | 36.02 |
|
| Rezolute Com New (RZLT) | 0.7 | $7.7M | -17% | 816k | 9.40 |
|
| Xenon Pharmaceuticals (XENE) | 0.7 | $7.6M | -27% | 189k | 40.15 |
|
| Ascendis Pharma A/s Sponsored Adr (ASND) | 0.7 | $7.2M | +2492% | 36k | 198.81 |
|
| Savara (SVRA) | 0.7 | $7.1M | -44% | 2.0M | 3.57 |
|
| Sarepta Therapeutics (SRPT) | 0.6 | $6.7M | +31% | 350k | 19.27 |
|
| Revolution Medicines (RVMD) | 0.6 | $6.5M | +3% | 139k | 46.70 |
|
| Bridgebio Oncology Therapeut Com New | 0.5 | $5.8M | NEW | 501k | 11.58 |
|
| Verona Pharma Sponsored Ads (VRNA) | 0.5 | $5.5M | +80% | 52k | 106.71 |
|
| Oaktree Acquisition Corp Iii Unit 10/04/2029 (OACCU) | 0.5 | $5.5M | 517k | 10.61 |
|
|
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 0.5 | $5.4M | -22% | 268k | 20.20 |
|
| Rhythm Pharmaceuticals (RYTM) | 0.5 | $5.0M | +9% | 50k | 100.99 |
|
| Atai Life Sciences Nv SHS (ATAI) | 0.5 | $4.8M | NEW | 913k | 5.29 |
|
| United Therapeutics Corporation (UTHR) | 0.4 | $4.7M | NEW | 11k | 419.21 |
|
| Viking Therapeutics (VKTX) | 0.4 | $4.6M | +159% | 176k | 26.28 |
|
| Bridgebio Pharma Note 2.250% 2/0 (Principal) | 0.4 | $4.4M | -99% | 45k | 98.83 |
|
| Replimune Group (REPL) | 0.4 | $4.3M | +9793% | 1.0M | 4.19 |
|
| Nektar Therapeutics Com New (NKTR) | 0.4 | $4.1M | +41% | 72k | 56.90 |
|
| Spdr Series Trust S&p Biotech Put Option (XBI) | 0.4 | $4.0M | NEW | 40k | 100.20 |
|
| Fulcrum Therapeutics (FULC) | 0.4 | $3.8M | +680% | 417k | 9.20 |
|
| Establishment Labs Holdings Ord (ESTA) | 0.3 | $3.7M | +262% | 91k | 40.99 |
|
| Sanofi Sa Sponsored Adr (SNY) | 0.3 | $3.5M | +642% | 74k | 47.20 |
|
| Krystal Biotech (KRYS) | 0.3 | $3.3M | NEW | 19k | 176.53 |
|
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 0.3 | $3.3M | 114k | 28.44 |
|
|
| Merus N V (MRUS) | 0.3 | $3.1M | +81% | 33k | 94.15 |
|
| Mineralys Therapeutics (MLYS) | 0.3 | $3.0M | -74% | 78k | 37.92 |
|
| Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA) | 0.3 | $2.9M | +32% | 75k | 38.83 |
|
| Celldex Therapeutics Com New (CLDX) | 0.3 | $2.8M | +90% | 109k | 25.87 |
|
| Zura Bio Class A Ord Shs (ZURA) | 0.3 | $2.8M | -34% | 652k | 4.33 |
|
| Bridgebio Pharma Note 2.500% 3/1 (Principal) | 0.3 | $2.8M | -99% | 20k | 140.57 |
|
| Vertex Pharmaceuticals Incorporated (VRTX) | 0.3 | $2.7M | NEW | 7.0k | 391.64 |
|
| Arcellx Common Stock (ACLX) | 0.2 | $2.6M | +125% | 32k | 82.10 |
|
| Biogen Idec (BIIB) | 0.2 | $2.5M | +252% | 18k | 140.08 |
|
| Delcath Sys Com New (DCTH) | 0.2 | $2.4M | +50% | 224k | 10.75 |
|
| Avidity Biosciences Ord (RNA) | 0.2 | $2.3M | NEW | 54k | 43.57 |
|
| Madrigal Pharmaceuticals (MDGL) | 0.2 | $2.2M | +364% | 4.9k | 458.66 |
|
| A Spac Iii Acquisition Corp Ord Shs Cl A (ASPC) | 0.2 | $2.2M | 215k | 10.34 |
|
|
| Masimo Corporation (MASI) | 0.2 | $2.2M | NEW | 15k | 147.55 |
|
| Miragen Therapeutics (VRDN) | 0.2 | $2.2M | -40% | 102k | 21.58 |
|
| Summit Therapeutics (SMMT) | 0.2 | $2.1M | -8% | 103k | 20.66 |
|
| Cidara Therapeutics Com New (CDTX) | 0.2 | $2.1M | 22k | 95.76 |
|
|
| Regenxbio Inc equity us cm (RGNX) | 0.2 | $2.0M | 205k | 9.65 |
|
|
| Korro Bio (KRRO) | 0.2 | $1.9M | -41% | 40k | 47.89 |
|
| Rocket Pharmaceuticals (RCKT) | 0.2 | $1.9M | +108% | 576k | 3.26 |
|
| Omniab (OABI) | 0.2 | $1.7M | +234% | 1.1M | 1.60 |
|
| Arrowhead Pharmaceuticals (ARWR) | 0.2 | $1.7M | -9% | 50k | 34.49 |
|
| Soleno Therapeutics (SLNO) | 0.2 | $1.7M | +45% | 25k | 67.60 |
|
| Dynavax Technologies Corp Com New (DVAX) | 0.2 | $1.7M | 170k | 9.93 |
|
|
| Alkermes SHS (ALKS) | 0.2 | $1.7M | +24% | 56k | 30.00 |
|
| Monte Rosa Therapeutics (GLUE) | 0.2 | $1.6M | NEW | 216k | 7.41 |
|
| Merck & Co (MRK) | 0.1 | $1.6M | +163% | 19k | 83.93 |
|
| Cohen Circle Acquisit Corp I Unit 07/01/2030 | 0.1 | $1.5M | NEW | 150k | 10.28 |
|
| Acumen Pharmaceuticals (ABOS) | 0.1 | $1.5M | -2% | 891k | 1.71 |
|
| Xencor (XNCR) | 0.1 | $1.5M | +50% | 129k | 11.73 |
|
| Urogen Pharma (URGN) | 0.1 | $1.5M | +650% | 75k | 19.95 |
|
| Agios Pharmaceuticals (AGIO) | 0.1 | $1.5M | +3% | 37k | 40.14 |
|
| Ww Intl Com New (WW) | 0.1 | $1.4M | NEW | 53k | 27.36 |
|
| Astria Therapeutics (ATXS) | 0.1 | $1.4M | -22% | 194k | 7.28 |
|
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.1 | $1.3M | -81% | 54k | 24.25 |
|
| Cortexyme (QNCX) | 0.1 | $1.3M | +442% | 775k | 1.63 |
|
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 0.1 | $1.2M | +391% | 169k | 7.17 |
|
| Pfizer (PFE) | 0.1 | $1.1M | +12% | 44k | 25.48 |
|
| Acasti Pharma (GRCE) | 0.1 | $1.0M | +98% | 351k | 2.98 |
|
| Nuvalent Inc-a (NUVL) | 0.1 | $1.0M | 12k | 86.48 |
|
|
| Best Spac I Acquisition Corp Unit 05/27/2030 (BSAAU) | 0.1 | $1.0M | 100k | 10.16 |
|
|
| Electronic Arts (EA) | 0.1 | $996k | NEW | 4.9k | 201.70 |
|
| Biontech Se Sponsored Ads (BNTX) | 0.1 | $986k | NEW | 10k | 98.62 |
|
| Contineum Therapeutics Cl A (CTNM) | 0.1 | $916k | -53% | 78k | 11.75 |
|
| Anteris Technologies Global (AVR) | 0.1 | $889k | -62% | 198k | 4.50 |
|
| Tectonic Therapeutic (TECX) | 0.1 | $879k | -23% | 56k | 15.69 |
|
| Wave Life Sciences SHS (WVE) | 0.1 | $872k | +3% | 119k | 7.32 |
|
| Keen Vision Acquisition Corp SHS Call Option (KVAC) | 0.1 | $863k | 75k | 11.51 |
|
|
| Pharvaris N V (PHVS) | 0.1 | $851k | 34k | 24.95 |
|
|
| Novocure Ord Shs (NVCR) | 0.1 | $827k | NEW | 64k | 12.92 |
|
| Eli Lilly & Co. (LLY) | 0.1 | $763k | +100% | 1.0k | 763.00 |
|
| Larimar Therapeutics (LRMR) | 0.1 | $761k | 236k | 3.23 |
|
|
| Scholar Rock Hldg Corp (SRRK) | 0.1 | $748k | -49% | 20k | 37.24 |
|
| Denali Therapeutics (DNLI) | 0.1 | $748k | +44% | 52k | 14.52 |
|
| Biohaven (BHVN) | 0.1 | $741k | -13% | 49k | 15.01 |
|
| Dyne Therapeutics (DYN) | 0.1 | $729k | +33% | 58k | 12.65 |
|
| Aclaris Therapeutics (ACRS) | 0.1 | $710k | NEW | 374k | 1.90 |
|
| Mei Pharma | 0.1 | $708k | NEW | 292k | 2.42 |
|
| Gossamer Bio Call Option (GOSS) | 0.1 | $704k | +17% | 268k | 2.63 |
|
| Arvinas Ord (ARVN) | 0.1 | $704k | -35% | 83k | 8.52 |
|
| Supernus Pharmaceuticals (SUPN) | 0.1 | $689k | NEW | 14k | 47.79 |
|
| Ceridian Hcm Hldg (DAY) | 0.1 | $689k | NEW | 10k | 68.89 |
|
| Maze Therapeatics (MAZE) | 0.1 | $675k | NEW | 26k | 25.93 |
|
| Edgewise Therapeutics (EWTX) | 0.1 | $649k | 40k | 16.22 |
|
|
| Alibaba Group Hldg Sponsored Ads (BABA) | 0.1 | $640k | NEW | 3.6k | 178.73 |
|
| Geron Corporation (GERN) | 0.1 | $625k | +3% | 456k | 1.37 |
|
| Olema Pharmaceuticals (OLMA) | 0.1 | $599k | NEW | 61k | 9.79 |
|
| Silverback Therapeutics (SPRY) | 0.1 | $595k | NEW | 59k | 10.05 |
|
| Spyre Therapeutics Com New (SYRE) | 0.1 | $571k | 34k | 16.76 |
|
|
| American Exceptionalism Acqu Ord Cl A | 0.1 | $547k | NEW | 50k | 10.93 |
|
| Ideaya Biosciences (IDYA) | 0.1 | $544k | NEW | 20k | 27.21 |
|
| Lenz Therapeutics (LENZ) | 0.1 | $541k | NEW | 12k | 46.58 |
|
| Neurogene (NGNE) | 0.0 | $531k | +3% | 31k | 17.33 |
|
| Brighthouse Finl (BHF) | 0.0 | $531k | NEW | 10k | 53.08 |
|
| Globa Terra Acquisition Cor Unit 99/99/9999 | 0.0 | $509k | NEW | 50k | 10.17 |
|
| Phathom Pharmaceuticals (PHAT) | 0.0 | $505k | -32% | 43k | 11.77 |
|
| Wisdomtree Tr Floatng Rat Trea (USFR) | 0.0 | $503k | 10k | 50.27 |
|
|
| Kezar Life Sciences Com New (KZR) | 0.0 | $487k | -15% | 125k | 3.90 |
|
| Kura Oncology (KURA) | 0.0 | $487k | +60% | 55k | 8.85 |
|
| Assembly Biosciences Com New (ASMB) | 0.0 | $485k | NEW | 19k | 25.60 |
|
| Kiora Pharmaceuticals (KPRX) | 0.0 | $467k | 168k | 2.78 |
|
|
| Apellis Pharmaceuticals (APLS) | 0.0 | $453k | +17% | 20k | 22.63 |
|
| Inspire Med Sys (INSP) | 0.0 | $445k | NEW | 6.0k | 74.20 |
|
| Intelligent Bio Solutions In (INBS) | 0.0 | $435k | NEW | 426k | 1.02 |
|
| Surgery Partners (SGRY) | 0.0 | $433k | -50% | 20k | 21.64 |
|
| Structure Therapeutics Sponsored Ads (GPCR) | 0.0 | $426k | 15k | 28.00 |
|
|
| Avalo Therapeutics Com New (AVTX) | 0.0 | $412k | -69% | 32k | 12.71 |
|
| Tenax Therapeutics Com New (TENX) | 0.0 | $407k | -65% | 53k | 7.61 |
|
| Vistagen Therapeutics Ord (VTGN) | 0.0 | $401k | -73% | 113k | 3.55 |
|
| Oruka Therapeutics (ORKA) | 0.0 | $401k | -85% | 21k | 19.23 |
|
| Guardant Health (GH) | 0.0 | $375k | NEW | 6.0k | 62.48 |
|
| Jd.com Spon Ads Cl A (JD) | 0.0 | $350k | NEW | 10k | 34.98 |
|
| Atyr Pharma Com New Call Option (ATYR) | 0.0 | $348k | +864% | 482k | 0.72 |
|
| Pulmonx Corp (LUNG) | 0.0 | $348k | +4% | 215k | 1.62 |
|
| Context Therapeutics (CNTX) | 0.0 | $340k | 351k | 0.97 |
|
|
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 0.0 | $330k | -9% | 2.5k | 131.80 |
|
| Avantor (AVTR) | 0.0 | $312k | +150% | 25k | 12.48 |
|
| Agriculture & Nat Sol Acq Shs Cl A (ANSC) | 0.0 | $296k | 27k | 10.92 |
|
|
| Akero Therapeutics (AKRO) | 0.0 | $292k | -81% | 6.1k | 47.48 |
|
| Nurix Therapeutics (NRIX) | 0.0 | $288k | 31k | 9.24 |
|
|
| Procap Acquisition Corp Unit 05/16/2030 (PCAPU) | 0.0 | $283k | +152% | 27k | 10.50 |
|
| Harmony Biosciences Hldgs In (HRMY) | 0.0 | $282k | NEW | 10k | 27.56 |
|
| Ultragenyx Pharmaceutical (RARE) | 0.0 | $271k | NEW | 9.0k | 30.08 |
|
| Eliem Therapeutics (CLYM) | 0.0 | $268k | +11% | 134k | 2.01 |
|
| BioMarin Pharmaceutical (BMRN) | 0.0 | $265k | 4.9k | 54.16 |
|
|
| Ventyx Biosciences (VTYX) | 0.0 | $254k | -51% | 82k | 3.11 |
|
| Alumis (ALMS) | 0.0 | $245k | +62% | 61k | 3.99 |
|
| Cassava Sciences (SAVA) | 0.0 | $236k | NEW | 81k | 2.91 |
|
| Therapeuticsmd Com New (TXMD) | 0.0 | $225k | 209k | 1.07 |
|
|
| Kala Bio Com New (KALA) | 0.0 | $217k | -5% | 142k | 1.53 |
|
| Spero Therapeutics (SPRO) | 0.0 | $217k | -19% | 116k | 1.88 |
|
| Bicara Therapeutics (BCAX) | 0.0 | $216k | -40% | 14k | 15.79 |
|
| Inflarx Nv (IFRX) | 0.0 | $214k | NEW | 160k | 1.34 |
|
| Day One Biopharmaceuticals I (DAWN) | 0.0 | $198k | 28k | 7.05 |
|
|
| Cybin Com New (CYBN) | 0.0 | $196k | NEW | 33k | 5.89 |
|
| Compass Therapeutics (CMPX) | 0.0 | $175k | +100% | 50k | 3.50 |
|
| Recursion Pharmaceuticals In Cl A (RXRX) | 0.0 | $171k | 35k | 4.88 |
|
|
| Pepgen (PEPG) | 0.0 | $170k | +81% | 37k | 4.62 |
|
| Karyopharm Therapeutics Com New (KPTI) | 0.0 | $164k | NEW | 25k | 6.54 |
|
| Voyager Therapeutics (VYGR) | 0.0 | $164k | -56% | 35k | 4.67 |
|
| Protara Therapeutics Com Stk (TARA) | 0.0 | $153k | -71% | 35k | 4.35 |
|
| Achieve Life Sciences (ACHV) | 0.0 | $151k | +10% | 48k | 3.15 |
|
| Clover Health Investments Com Cl A (CLOV) | 0.0 | $148k | 48k | 3.06 |
|
|
| 4d Molecular Therapeutics In (FDMT) | 0.0 | $145k | NEW | 17k | 8.69 |
|
| Pmv Pharmaceuticals (PMVP) | 0.0 | $141k | 101k | 1.40 |
|
|
| Generation Bio Com New (GBIO) | 0.0 | $136k | NEW | 22k | 6.12 |
|
| Corbus Pharmaceuticals Hldgs Com New (CRBP) | 0.0 | $129k | NEW | 10k | 12.65 |
|
| Kalvista Pharmaceuticals (KALV) | 0.0 | $122k | 10k | 12.18 |
|
|
| Iovance Biotherapeutics Call Option (IOVA) | 0.0 | $109k | NEW | 50k | 2.17 |
|
| Organon & Co Common Stock (OGN) | 0.0 | $107k | 10k | 10.68 |
|
|
| Silence Therapeutics Ads (SLN) | 0.0 | $97k | 19k | 5.19 |
|
|
| Zentalis Pharmaceuticals (ZNTL) | 0.0 | $76k | 50k | 1.51 |
|
|
| Terns Pharmaceuticals (TERN) | 0.0 | $75k | -64% | 10k | 7.51 |
|
| Solidion Technology Com New Call Option (STI) | 0.0 | $63k | NEW | 14k | 4.64 |
|
| A Spac Iii Acquisition Corp Right 01/02/2026 (ASPCR) | 0.0 | $41k | 215k | 0.19 |
|
|
| Biomx Com New (PHGE) | 0.0 | $41k | -74% | 78k | 0.53 |
|
| Sab Biotherapeutics Com New (SABS) | 0.0 | $30k | NEW | 15k | 2.01 |
|
| Minerva Neurosciences Com New (NERV) | 0.0 | $26k | 12k | 2.10 |
|
|
| Mural Oncology Pub Ord Shs (MURA) | 0.0 | $25k | 12k | 2.07 |
|
|
| Ibio Com New (IBIO) | 0.0 | $22k | -50% | 27k | 0.83 |
|
| Proqr Thrapeutics N V Shs Euro (PRQR) | 0.0 | $21k | 10k | 2.13 |
|
|
| Fractyl Health (GUTS) | 0.0 | $21k | NEW | 13k | 1.59 |
|
| Coherus Biosciences (CHRS) | 0.0 | $17k | 10k | 1.64 |
|
|
| Ovid Therapeutics (OVID) | 0.0 | $17k | -88% | 13k | 1.30 |
|
| Leap Therapeutics Com New (LPTX) | 0.0 | $12k | -35% | 26k | 0.45 |
|
Past Filings by ADAR1 Capital Management
SEC 13F filings are viewable for ADAR1 Capital Management going back to 2023
- ADAR1 Capital Management 2025 Q3 filed Nov. 14, 2025
- ADAR1 Capital Management 2025 Q2 filed Aug. 14, 2025
- ADAR1 Capital Management 2025 Q1 filed May 15, 2025
- ADAR1 Capital Management 2024 Q4 filed Feb. 13, 2025
- ADAR1 Capital Management 2024 Q3 filed Nov. 14, 2024
- ADAR1 Capital Management 2024 Q2 filed Aug. 13, 2024
- ADAR1 Capital Management 2024 Q1 filed May 15, 2024
- ADAR1 Capital Management 2023 Q4 filed Feb. 14, 2024